Renaissance Technologies
PETX

Renaissance Technologies’s Aratana Therapeutics, Inc. PETX Stock Holding History

Renaissance Technologies’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-408,889
Closed -$2.11M – 3883
2019
Q2 		$2.11M Buy
408,889
+218,100
+114% +$980K ﹤0.01% 2293
2019
Q1 		$687K Buy
190,789
+120,100
+170% +$520K ﹤0.01% 2821
2018
Q4 		$433K Sell
70,689
-193,411
-73% -$1.18M ﹤0.01% 2914
2018
Q3 		$1.54M Sell
264,100
-117,300
-31% -$586K ﹤0.01% 2408
2018
Q2 		$1.62M Sell
381,400
-202,300
-35% -$1.02M ﹤0.01% 2381
2018
Q1 		$2.57M Buy
583,700
+458,900
+368% +$2.05M ﹤0.01% 2198
2017
Q4 		$656K Buy
124,800
+44,600
+56% +$273K ﹤0.01% 2817
2017
Q3 		$492K Buy
+80,200
New +$508K ﹤0.01% 2792
2017
Q1 		– Sell
-87,608
Closed -$629K – 3517
2016
Q4 		$629K Sell
87,608
-19,492
-18% -$158K ﹤0.01% 2705
2016
Q3 		$1M Sell
107,100
-135,500
-56% -$1.13M ﹤0.01% 2562
2016
Q2 		$1.53M Buy
242,600
+224,200
+1,218% +$1.44M ﹤0.01% 2350
2016
Q1 		$102K Sell
18,400
-353,373
-95% -$1.33M ﹤0.01% 3212
2015
Q4 		$2.07M Buy
+371,773
New +$2.46M ﹤0.01% 2087

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Renaissance Technologies's PETX Position: Q3 2019 in Review

Renaissance Technologies sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 408,889 shares — an estimated $2.11M sold.

Renaissance Technologies first reported a position in PETX in Q4 2015 and held it in 13 quarters. The position peaked at $2.57M in Q1 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Renaissance Technologies reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Renaissance Technologies sold 408,889 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $2.11M.
  • Renaissance Technologies first reported a position in Aratana Therapeutics, Inc. in Q4 2015 and held it in 13 quarters.
  • Renaissance Technologies's Aratana Therapeutics, Inc. position peaked at $2.57M in Q1 2018.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Renaissance Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.